Table 3 Postoperative and follow-up
Omental group N (%) or (\(\stackrel{-}{x}\)± s) | Non-omental group N (%) or (\(\stackrel{-}{x}\)± s) | F | P | X 2 | |
|---|---|---|---|---|---|
Postoperative laboratory values | |||||
Alanine transaminase (U/L) | 41.49 ± 43.62 | 33.57 ± 23.72 | 0.585 | 0.448 | |
Aspartate transaminase (U/L) | 36.26 ± 36.23 | 30.90 ± 21.51 | 0.346 | 0.559 | |
Total bilirubin(µmol/L) | 13.93 ± 5.49 | 13.60 ± 4.42 | 0.053 | 0.818 | |
Alkaline phosphatase(U/L) | 82.81 ± 19.10 | 73.10 ± 26.29 | 2.296 | 0.136 | |
γ-Glutamyl transpeptidase(U/L) | 32.57 ± 24.11 | 28.67 ± 27.57 | 0.309 | 0.581 | |
Albumin(g/L) | 34.30 ± 3.21 | 35.49 ± 3.50 | 1.664 | 0.203 | |
Clavien-Dindo grade complication occurrence | |||||
I | 1(2.86%) | 3(14.2%) | |||
II | 0 | 1(4.8%) | |||
Postoperative complications | |||||
Perihepatic effusion | 1(2.9%) | 1(4.8%) | |||
Ascites | 0 | 1(4.8%) | |||
Fever | 0 | 1(4.8%) | |||
Symptom resolution | 37(94.87%) | 25(96.15%) | |||
Operation time (min) | 78.31 ± 17.36 | 59.05 ± 15.78 | 17.272 | 1.164E-4 | |
Hospitalization time (day) | 5.71 ± 3.73 | 8.30 ± 5.01 | 4.751 | 0.034 | |
Hospitalization Expenses (RMB) | 17236.97 ± 4645.39 | 17970.39 ± 5928.06 | 0.259 | 0.613 | |
Recurrence 6 months after surgery | 0(0.00%) | 3(14.28%) | 0.022 | 5.283 | |
Recurrence 12 months after surgery | 1(2.86%) | 8(38.10%) | 5.089E-4 | 12.083 |